PDGF-β is released in the cerebral spinal fluid (CSF) from pericytes and is a specific marker for pericyte injury associated with a loss of integrity in the blood–brain barrier [48], which declines in normal aging and more rapidly in AD. The gene discussed is PDGFB; the disease is Alzheimer disease.